Speramus India Profile
Key Indicators
- Authorised Capital ₹ 1.58 Cr
- Paid Up Capital ₹ 1.58 Cr
- Company Age 2 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.98 Cr
About Speramus India
Speramus India Private Limited (SIPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 July 2022 (Two years and seven months 17 days old ). Its registered office is in Kamrup, Assam, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.58 Cr and a paid-up capital of Rs 1.58 Cr.
The company currently has active open charges totaling ₹4.98 Cr.
Safikul Haque, Baser Ali, Hridoy Das, and Two other members serve as directors at the Company.
Company Details
-
Location
Kamrup, Assam, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85300AS2022PTC023235
-
Company No.
023235
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Jul 2022
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Speramus India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Safikul Haque
|
Managing Director | 01-Jul-2022 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Baser Ali
|
Director | 01-Jul-2022 | Current |
|
Hridoy Das
|
Director | 21-Nov-2022 | Current |
|
Anirudha Dewri
|
Director | 27-Apr-2023 | Current |
|
Tazkia Begam
|
Whole-Time Director | 29-Jan-2024 | Current |
Financial Performance of Speramus India.
Speramus India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Speramus India?
Unlock access to Speramus India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹4.98 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 4.98 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2023 | State Bank Of India | ₹4.98 Cr | Open |
How Many Employees Work at Speramus India?
Unlock and access historical data on people associated with Speramus India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Speramus India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Speramus India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.